Antiarrhythmic therapy in patients with additional atrioventricular connective pathways: should we remember about it in the era of catheter ablation?

Tsaregorodtsev D.A.; Vasyukov S.S.; Sedov A.V.; Beraya M.M.; Sulimov V.A.

doi:https://doi.org/10.17116/kardio20169176-81

Tsaregorodtsev D.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Vasyukov S.S.

Chair of Faculty Therapy №1, Medical Faculty of I.M. Sechenov First Moscow State Medical University, Russia

Sedov A.V.

OOO Klinika innovatsionnoĭ khirurgii, Klin

Beraya M.M.

Chair of Faculty Therapy №1, Medical Faculty of I.M. Sechenov First Moscow State Medical University, Russia

Sulimov V.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Antiarrhythmic therapy in patients with additional atrioventricular connective pathways: should we remember about it in the era of catheter ablation?

Authors:

Tsaregorodtsev D.A., Vasyukov S.S., Sedov A.V., Beraya M.M., Sulimov V.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(1): 76‑81

DOI: 10.17116/kardio20169176-81

Read: 2106 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tsaregorodtsev DA, Vasyukov SS, Sedov AV, Beraya MM, Sulimov VA. Antiarrhythmic therapy in patients with additional atrioventricular connective pathways: should we remember about it in the era of catheter ablation? Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(1):76‑81. (In Russ.)
https://doi.org/10.17116/kardio20169176-81

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Catheter radiofrequency ablation (RFA) is preferable treatment for patients with ventricular pre-excitation syndromes. Its efficiency is currently exceeds 95%. However, in some cases there is need for prophylactic antiarrhythmic therapy. As a rule, need for it arises for a limited period of time (from diagnosis to intervention or between procedures in case of arrhythmia recurrence) or in case of RFA failure. Specific situations of antiarrhythmic therapy for Wolff-Parkinson-White syndrome, frequency and effectiveness of drugs from different classes are analyzed in the article. Choice of antiarrhythmic drug is shown based on electrophysiological properties of additional atrioventricular connections.

Keywords:

antiarrhythmic therapy

catheter radiofrequency ablation

Authors:

Tsaregorodtsev D.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Vasyukov S.S.

Chair of Faculty Therapy №1, Medical Faculty of I.M. Sechenov First Moscow State Medical University, Russia

Sedov A.V.

OOO Klinika innovatsionnoĭ khirurgii, Klin

Beraya M.M.

Chair of Faculty Therapy №1, Medical Faculty of I.M. Sechenov First Moscow State Medical University, Russia

Sulimov V.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Close metadata

References:

Bunin YU.А., Denisov O.N., Fedyakina L.F. Profilakticheskaya antiaritmicheskaya farmakoterapiya chastykh paroksizmov fibrillyatsii predserdij i nekotorykh vidov nadzheludochkovykh takhikardij propafenonom v sravnenii s platsebo [Prophylactic antiarrhythmic therapy of frequent paroxysmal atrial fibrillation and some types of supraventricular tachycardia using propafenone compared with placebo]. Rossijskij kardiologicheskij zhurnal. 2010;5:85:42- 47.(in Russian)
Zagraj А.P., Sokolov S.F., Golitsyn S.P., Malakhov V.I. Sravnitel'naya ehffektivnost' allapinina i ehtatsizina u bol'nykh s paroksizmal'nymi nadzheludochkovymi takhikardiyami, otsenennaya s pomoshh'yu chrespishhevodnoj ehlektrostimulyatsii serdtsa [Comparative efficacy of allapinine and etatsizine in patients with paroxysmal supraventricular tachycardia, assessed using transesophageal electrical stimulation of the heart]: Sbornik tezisov Pervogo Mezhdunarodnogo slavyanskogo kongressa po ehlektrokardiostimulyatsii i klinicheskoj ehlektrofiziologii serdtsa. SPb 1993;123. (in Russian)
Revishvili А.SH., i dr. Klinicheskie rekomendatsii po provedeniyu ehlektrofiziologicheskikh issledovanij, kateternoj ablyatsii i primeneniyu implantiruemykh antiaritmicheskikh ustrojstv [Clinical guidelines for the electrophysiologic studies, catheter ablation and the use of implantable antiarrhythmic devices]. Vserossijskoe nauchnoe obshhestvo spetsialistov po klinicheskoj ehlektrofiziologii, aritmologii i kardiostimulyatsii (VNOА).-3-e izd., dop. i pererab. M.: MАKS Press. 2013;357-358. (in Russian)
Koshumbaeva K.M., Belokopit I.N., Kim Z.G., Makhanov D.I. EHffektivnost' ehtatsizina u bol'nykh s paroksizmal'nymi atrioventrikulyarnymi takhikardiyami [Efficacy of etatsizine in patients with paroxysmal atrioventricular tachycardia]. www. Electrophysiology. ru›conference/6/102.pdf. (in Russian)
Matyushin G.V., SHul'man V.А., Balog А.I., i dr. Primenenie chrespishhevodnoj stimulyatsii levogo predserdiya dlya otsenki ehffektivnosti lecheniya kordaronom patsientov s atrioventrikulyarnymi takhikardiyami [The use of transesophageal pacing of the left atrium to measure the effectiveness of cordarone in patients with atrioventricular tachycardia]. Terapevticheskij arkhiv. 1998;6:47-50. (in Russian)
SHugushev KH.KH. Novaya gruppa antiaritmicheskikh preparatov - proizvodnye fenotiazina - v lechenii I profilaktike narushenij ritma serdtsa (kliniko-ehksperimental'noe issledovanie) [A new group of anti-arrhythmic drugs - phenothiazines - in the treatment and prevention of cardiac arrhythmias (clinical and experimental study)]: Dis. … d-ra med. nauk. M. 1986;49. (in Russian)
YAshin C.M., Butaev T.D. Sindrom Vol'fa-Parkinsona-Uajta [Wolff-Parkinson-White syndrome]. SPb. 2009;88.(in Russian)
ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias. J Am Coll Cardiol. 2003 Oct 15;42:8:1493-1531.
Amasyali B, Kose S, Aytemir K, Kilic A, Kursaklioglu H, Isik E. A permanent junctional reciprocating tachycardia with an atypically located accessory pathway successfully ablated from within the middle cardiac vein. Heart Vessels. 2006 May;21(3):188-191.
Bashir Y, Betts TR, Rajappan K. Cardiac electrophysiology and catheter ablation. Oxford University Press. 2010;361- 393.
DiLorenzo MP, Pass RH, Nappo L, Ceresnak SR. Ablating the anteroseptal accessory pathway-ablation via the right internal jugular vein may improve safety and efficacy. J Interv Card Electrophysiol. 2012 Dec;35(3):293-299.
Drago F, Silvetti MS, Mazza A, et al. Permanent junctional reciprocating tachycardia in infants and children: effectiveness of medical and non-medical treatment. Ital Heart J. 2001 Jun;2(6):456- 461.
Gaita F, Montefusco A, Riccardi R, et al. Acute and long-term outcome of transvenous cryothermal catheter ablation of supraventricular arrhythmias involving the perinodal region. J Cardiovasc Med (Hagerstown). 2006 Nov;7(11):785-792.
Kang KT, Potts JE, Radbill AE, et al. Permanent junctional reciprocating tachycardia in children: a multicenter experience. Heart Rhythm. 2014 Aug;11(8):1426-1432.
Kalarus Z, Prokopczuk J, Kowalski O, et al. Permanent junction reciprocating tachycardia-treatment with radiofrequency current ablation. Pol Arch Med Wewn. 2002 Jul;108(1):663-669.
Mabo P, Lelong B, Kermarrec A, et al. Long-term outcome of a hospital series of patients with atrio-ventricular accessory pathway. Arch Mal Coeur Vaiss. 1992 Nov;85(11):1535-1543.
Pappone С, Vicedomini G, Manguso F, et al. Wolff-Parkinson- White Syndrome in the Era of Catheter Ablation. Insights From a Registry Study of 2169 Patients. Circulation. 2014;130:811-819.
Piwowarska W, Sniezek-Maciejewska M. Clinical value of cordarone as an antiarrhythmic agent. Cor et Vasa. 1987;29(4):269-277.
Sacher F, Wright M, Tedrow UB, et al. Wolff-Parkinson-White ablation after a prior failure: a 7-year multicentre experience. Europace. 2010 Jun;12(6):835-841.
Spector P, Reynolds MR, Calkins H, et al. Metaanalysis of ablation of atrial flutter and supraventricular tachycardia. Am J Cardiol. 2009 Sep 1;104(5):671-677.
Tuzcu EM, Gilbo J, Masterson M, Maloney JD. The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias. Cleve Clin J Med. 1989 May;56(3):238-242.
Vaksmann G, D’Hoinne C, Lucet V. Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome. Heart. 2006 Jan;92(1):101-104.
Vidaillet HJJr, Pressley JC, Henke E, et al. Familial occurrence of accessory atrioventricular pathways (preexcitation syndrome). N Engl J Med. 1987;317:65-69.
Wellens HJJ, Brugada P, Abdollah H. Effects of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff- Parkinson-White syndrome. Am Heart J. 1983;106:876-879.
Yeh SJ, Wang CC, Wen MS, et al. Characteristics and radiofrequency ablation therapy of intermediate septal accessory pathway. Am J Cardiol. 1994;73:50-56.